Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
- Resource Type
- Article
- Source
- Pediatric Blood & Cancer; Dec2023, Vol. 70 Issue 12, p1-8, 8p
- Subject
- Language
- ISSN
- 15455009